DUKEHEALTH.ORG
SCHOOL OF MEDICINE
DUKE UNIVERSITY
Clinical Trials at Duke Comprehensive Cancer Center
If you would like to inquire about all open trials, please contact Gretchen Sanders, RN at (919) 684-6858 or Krista Rowe, RN, MSN (919)681-7491.
| Trial | Phase | Melanoma and other skin cancers |
| 00012741 | III | A Double Blind, Randomized Placebo-Controlled Phase III Study to Assess the Efficacy of recMAGE-A3 + AS15. ASCI as Adjuvant Therapy in Patients with MAGE-A3 Positive Resected Stage III Melanoma. |
| 00013574 | III | A Randomized Phase III Clinical Trial to Evaluate the Efficacy and Safety of Treatment with OncoVEXGM-CSF Compared to Subcutaneously Administered GM-CSF in Previously Treated Melanoma Patients with Unresectable Stage IIIb, IIIc and IV Disease |
| 00006143 | N/A | Regional Therapies for Melanoma: The Role of Alkylating Drug Resistance Mechanisms in Malignant Melanoma that May Undermine the Efficacy of Hyperthermic Isolated Limb Perfusion with Melphalan. |
